NDC 0781-5527
Naratriptan
Naratriptan
Naratriptan is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc. The primary component is Naratriptan Hydrochloride.
| Product ID | 0781-5527_49acb238-7bf5-4f86-925f-c939b4ece684 |
| NDC | 0781-5527 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Naratriptan |
| Generic Name | Naratriptan |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-07-07 |
| Marketing End Date | 2019-11-08 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090288 |
| Labeler Name | Sandoz Inc |
| Substance Name | NARATRIPTAN HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/1 |
| Pharm Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| NDC Exclude Flag | N |